NCT02652507View on ClinicalTrials.gov

Dexmedetomidine and Ketamine in MRI

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Magnetic Resonance Imaging
Interventions
DRUG

Dexmedetomidine

2 mc/kg/h over ten minutes followed by a continuous infusion of 2 mcg/kg/h

DRUG

Ketamine

Bolus dose 2 mg/kg after first set of research images are obtained

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT02652507 - Dexmedetomidine and Ketamine in MRI | Biotech Hunter | Biotech Hunter